<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="review-article" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Ophthalmology Reports</journal-id><journal-title-group><journal-title xml:lang="en">Ophthalmology Reports</journal-title><trans-title-group xml:lang="ru"><trans-title>Офтальмологические ведомости</trans-title></trans-title-group></journal-title-group><issn publication-format="print">1998-7102</issn><issn publication-format="electronic">2412-5423</issn><publisher><publisher-name xml:lang="en">Eco-Vector</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">684364</article-id><article-id pub-id-type="doi">10.17816/OV684364</article-id><article-id pub-id-type="edn">GOVYMT</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>Lectures</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>Лекции</subject></subj-group><subj-group subj-group-type="article-type"><subject>Review Article</subject></subj-group></article-categories><title-group><article-title xml:lang="en">Chronic uveal traumatization syndrome: a complete description of symptoms</article-title><trans-title-group xml:lang="ru"><trans-title>Синдром хронической увеальной травматизации: полное описание симптомокомплекса</trans-title></trans-title-group><trans-title-group xml:lang="zh"><trans-title/></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0009-0006-3837-7382</contrib-id><name-alternatives><name xml:lang="en"><surname>Cherkashina</surname><given-names>Anna S.</given-names></name><name xml:lang="ru"><surname>Черкашина</surname><given-names>Анна Сергеевна</given-names></name><name xml:lang="zh"><surname></surname><given-names></given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>MD</p></bio><email>annaa.cherkashina@mail.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-7807-9036</contrib-id><contrib-id contrib-id-type="spin">3132-9163</contrib-id><name-alternatives><name xml:lang="en"><surname>Potemkin</surname><given-names>Vitaly V.</given-names></name><name xml:lang="ru"><surname>Потемкин</surname><given-names>Виталий Витальевич</given-names></name><name xml:lang="zh"><surname></surname><given-names></given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>MD, Dr. Sci. (Medicine)</p></bio><bio xml:lang="ru"><p>д-р мед. наук</p></bio><email>potem@inbox.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-0777-4861</contrib-id><contrib-id contrib-id-type="spin">7732-1150</contrib-id><name-alternatives><name xml:lang="en"><surname>Astakhov</surname><given-names>Sergey Yu.</given-names></name><name xml:lang="ru"><surname>Астахов</surname><given-names>Сергей Юрьевич</given-names></name><name xml:lang="zh"><surname></surname><given-names></given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>MD, Dr. Sci. (Medicine), Professor</p></bio><bio xml:lang="ru"><p>д-р мед. наук, профессор</p></bio><email>astakhov73@mail.ru</email></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-8666-1541</contrib-id><name-alternatives><name xml:lang="en"><surname>Terekhova</surname><given-names>Irina V.</given-names></name><name xml:lang="ru"><surname>Терехова</surname><given-names>Ирина Владимировна</given-names></name><name xml:lang="zh"><surname></surname><given-names></given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>MD</p></bio><email>irterehova@yandex.ru</email><xref ref-type="aff" rid="aff3"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-0776-4065</contrib-id><contrib-id contrib-id-type="spin">2380-2273</contrib-id><name-alternatives><name xml:lang="en"><surname>Belov</surname><given-names>Dmitrii F.</given-names></name><name xml:lang="ru"><surname>Белов</surname><given-names>Дмитрий Фёдорович</given-names></name><name xml:lang="zh"><surname></surname><given-names></given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>MD, Cand. Sci. (Medicine)</p></bio><bio xml:lang="ru"><p>канд. мед. наук</p></bio><email>belovd1990@gmail.com</email><xref ref-type="aff" rid="aff3"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">Saint Petersburg Multifield Hospital No. 2, Saint Petersburg</institution></aff><aff><institution xml:lang="ru">Городская многопрофильная больница № 2, Санкт-Петербург</institution></aff><aff><institution xml:lang="zh"></institution></aff></aff-alternatives><aff-alternatives id="aff2"><aff><institution xml:lang="en">Academican I.P. Pavlov First St. Petersburg State Medical University</institution></aff><aff><institution xml:lang="ru">Первый Санкт-Петербургский государственный медицинский университет им. акад. И.П. Павлова</institution></aff><aff><institution xml:lang="zh"></institution></aff></aff-alternatives><aff-alternatives id="aff3"><aff><institution xml:lang="en">Saint Petersburg Multifield Hospital No. 2, Saint Petersburg</institution></aff><aff><institution xml:lang="ru">Городская многопрофильная больница № 2, Санкт-Петербург</institution></aff></aff-alternatives><pub-date date-type="pub" iso-8601-date="2026-01-15" publication-format="electronic"><day>15</day><month>01</month><year>2026</year></pub-date><volume>18</volume><issue>4</issue><issue-title xml:lang="en"/><issue-title xml:lang="ru"/><issue-title xml:lang="zh"/><fpage>79</fpage><lpage>86</lpage><history><date date-type="received" iso-8601-date="2025-06-15"><day>15</day><month>06</month><year>2025</year></date><date date-type="accepted" iso-8601-date="2025-10-02"><day>02</day><month>10</month><year>2025</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2025, Eco-Vector</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2025, Эко-Вектор</copyright-statement><copyright-statement xml:lang="zh">Copyright ©; 2025,</copyright-statement><copyright-year>2025</copyright-year><copyright-holder xml:lang="en">Eco-Vector</copyright-holder><copyright-holder xml:lang="ru">Эко-Вектор</copyright-holder><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/">https://creativecommons.org/licenses/by-nc-nd/4.0/</ali:license_ref></license></permissions><self-uri xlink:href="https://journals.eco-vector.com/ov/article/view/684364">https://journals.eco-vector.com/ov/article/view/684364</self-uri><abstract xml:lang="en"><p>Currently, the long-term effects of phacoemulsification with intraocular lens implantation, including uncomplicated, are more frequently identified. Uveitis–glaucoma–hyphema syndrome, also known as Ellingson syndrome, is one of these complications, but the names cannot reflect its various manifestations. This condition shows no true signs of uveitis, and glaucomatous optic neuropathy is less common than ocular hypertension. The term “chronic uveal traumatization syndrome” demonstrates the pathogenesis of this condition, namely prolonged intraocular lens trauma to the iris and/or ciliary body. It develops when the intraocular lens is located in the ciliary sulcus or naturally in the fibrous capsular bag and in case of combined fixation. Chronic uveal traumatization syndrome is most common after implantation of an intraocular lens with a sharp optical and haptic edge. The condition is characterized by periodic blurring or a sharp decrease in vision and floaters, depending on the severity and location of intraocular hemorrhage. Pain, photophobia, and eye redness are signs of secondary ocular hypertension. An early and pathognomonic sign is defects in the iris pigmented layer at the site of its contact with the intraocular lens, detected using transillumination. Intraocular hemorrhages appear as microhyphema, hyphema, and vitreous hemorrhage. Anterior chamber flare is caused by abnormalities in the blood–aqueous barrier, dispersion of pigment and blood cells. Relapses usually include corneal edema associated with ocular hypertension, toxic effects of degradating blood, and endothelial decompensation. Corneal edema is not typical for primary open-angle glaucoma, even in case of high intraocular pressure, but it does not rule out their combination. Chronic uveal traumatization syndrome is associated with pseudo-phacodonesis, capsular contraction syndrome, and intraocular lens dislocation. Rare manifestations include cystoid macular edema and glaucomatous optic neuropathy caused by secondary glaucoma. Unlike uveitis, chronic uveal traumatization syndrome is not characterized by no precipitates, hypopyon, or blurred iris pattern. Ultrasound biomicroscopy assesses the intraocular lens position (in the sulcus ciliaris, combined, or intracapsular), decentration, tilt, or deformation, capsular bag fibrosis, Soemmering ring, iris prolapse, optic or haptic contact with the iris and ciliary body. Timely diagnosis and pathogenesis-directed therapy prevent optic nerve atrophy associated with secondary glaucoma.</p></abstract><trans-abstract xml:lang="ru"><p>В настоящее время всё чаще выявляются отдалённые последствия имплантации интраокулярных линз при факоэмульсификации, в том числе неосложнённой. Известный синдром «увеит–глаукома–гифема», или синдром Эллингсона, — одно из таких осложнений, однако эти названия не отражают всё многообразие его проявлений. При данном состоянии отсутствуют истинные признаки увеита, а глаукомная нейрооптикопатия встречается реже, чем офтальмогипертензия. Термин «синдром хронической увеальной травматизации» (СХУТ) демонстрирует патогенез данного процесса, а именно длительное травмирование интраокулярной линзой радужки и/или цилиарного тела. СХУТ развивается при нахождении интраокулярной линзы в борозде цилиарного тела, при её смешанной фиксации и при физиологичном положении в фиброзированном капсульном мешке. Наиболее часто СХУТ встречается после имплантации интраокулярной линзы с острым краем оптического и гаптических элементов. Для СХУТ характерны жалобы на периодическое затуманивание или резкое снижение зрения, плавающие помутнения перед взором, зависящие от интенсивности и локализации внутриглазного кровоизлияния. Боль, светобоязнь и покраснение глаза — признаки вторичной офтальмогипертензии. Ранний и патогномоничный признак — дефекты пигментного листка радужки в месте её контакта с интраокулярной линзой, определяемые при трансилюминации. Внутриглазные кровоизлияния проявляются в виде микрогифемы, гифемы, гемофтальма. Опалесценция влаги передней камеры — следствие нарушения гематоофтальмического барьера, дисперсии пигмента и взвеси форменных элементов крови. В период рецидивов чаще проявляется в виде отёка роговицы, связанного с офтальмогипертензией, токсическим воздействием распадающейся крови и декомпенсацией функции эндотелия. Отёк роговицы не характерен для первичной открытоугольной глаукомы, даже при высоком внутриглазном давлении, однако не исключает сочетание с ней. Характерна ассоциация СХУТ с псевдофакодонезом, синдромом контракции капсульного мешка, дислокацией интраокулярной линзы. Редкие проявления — кистозный макулярный отёк и развитие глаукомной оптической нейрооптикопатии вследствие вторичной глаукомы. В отличие от увеита не встречаются преципитаты, гипопион, стушёванность рисунка радужки. Ультразвуковая биомикроскопия позволяет оценить положение интраокулярной линзы: в <italic>sulcus ciliaris</italic>, смешанное или интракапсулярное; децентрацию интраокулярной линзы, её наклон, деформацию; фиброз капсульного мешка; кольцо Зоммеринга; прогиб радужки; контакт гаптического и/или оптического элементов ИОЛ с радужкой и цилиарным телом. Своевременная диагностика и патогенетическое лечение предотвращают развитие атрофии зрительного нерва вследствие вторичной глаукомы.</p></trans-abstract><trans-abstract xml:lang="zh"><p/></trans-abstract><kwd-group xml:lang="en"><kwd>phacoemulsification</kwd><kwd>intraocular lens</kwd><kwd>complication</kwd><kwd>pseudo-phacodonesis</kwd><kwd>capsular contraction syndrome</kwd><kwd>Ellingson syndrome</kwd><kwd>uveitis–glaucoma–hyphema syndrome</kwd><kwd>chronic uveal traumatization syndrome</kwd><kwd>vitreous hemorrhage</kwd><kwd>ocular hypertension</kwd><kwd>glaucoma</kwd><kwd>cystoid macular edema</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>факоэмульсификация</kwd><kwd>интраокулярная линза</kwd><kwd>осложнение</kwd><kwd>псевдофакодонез</kwd><kwd>синдром контракции капсульного мешка</kwd><kwd>синдром Эллингсона</kwd><kwd>синдром увеит–глаукома–гифема</kwd><kwd>синдром хронической увеальной травматизации</kwd><kwd>гемофтальм</kwd><kwd>офтальмогипертензия</kwd><kwd>глаукома</kwd><kwd>кистозный макулярный отёк</kwd></kwd-group><funding-group/></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>Jaffe NS. History of cataract surgery. Ophthalmology. 1996;103(8S): S5–16. doi: 10.1016/s0161-6420(96)30760-4</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>Sen S, Zeppieri M, Tripathy K. Uveitis glaucoma hyphema syndrome. In: StatPearls. Treasure Island (FL): StatPearls Publ.; 2025. PMID: 35593837</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>Zemba M, Camburu G. Uveitis–glaucoma–hyphaema syndrome. General review. Rom J Ophthalmol. 2017;61(1):11–17. doi: 10.22336/rjo.2017.3</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>Ramakrishnan MS, Wald KJ. Current concepts of the uveitis–glaucoma–hyphema (UGH) syndrome. Curr Eye Res. 2023;48(6):529–535. doi: 10.1080/02713683.2022.2156547</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>Accorinti M, Saturno MC, Paroli MP, et al. Uveitis–glaucoma–hyphema syndrome: clinical features and differential diagnosis. Ocul Immunol Inflamm. 2022;30(6):1408–1413. doi: 10.1080/09273948.2021.1881563</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>Ellingson FT. The uveitis–glaucoma–hyphema syndrome associated with the Mark VIII anterior chamber lens implant. J Am Intra-Ocul Implant Soc. 1978;4(2):50–53. doi: 10.1016/s0146-2776(78)80054-8</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation>Siepser SB, Kline OR Jr. Scanning electron microscopy of removed intraocular lenses. J Am Intraocul Implant Soc. 1983;9(2):176–183. doi: 10.1016/s0146-2776(83)80034-2</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation>Apple DJ, Mamlis N, Loftfield K, et al. Complications of intraocular lenses. A historical and histopathological review. Surv Ophthalmol. 1984;29(1):1–54. doi: 10.1016/0039-6257(84)90113-9</mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation>Belov DF, Nikolaenko VP, Shuvaev DA, et al. The uveitis–glaucoma–hyphema syndrome. Part 1. Pathogenesis, clinical features, diagnosis. Ophthalmology Reports. 2024;17(2):31–39. doi: 10.17816/OV626405 EDN: VUKSVG</mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation>Jasinskas V, Vaiciuliene R, Varoniukaite A, Speckauskas M. Novel microsurgical management of uveitis–glaucoma–hyphema syndrome. Int Ophthalmol. 2019;39(7):1607–1612. doi: 10.1007/s10792-018-0972-5</mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation>Bryant TK, Feinberg EE, Peeler CE. Uveitis–glaucoma–hyphema syndrome secondary to a Soemmerring ring. J Cataract Refract Surg. 2017;43(7):985–987. doi: 10.1016/j.jcrs.2017.07.002</mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation>Thakur M, Bhatia P, Chandrasekhar G, Senthil S. Recurrent uveitis and pigment dispersion in an eye with in-the-bag acrylic foldable intraocular lens. BMJ Case Rep. 2016;2016:bcr2015213968. doi: 10.1136/bcr-2015-213968</mixed-citation></ref><ref id="B13"><label>13.</label><mixed-citation>Mamalis N. Explantation of intraocular lenses. Curr Opin Ophthalmol. 2000;11(4):289–295. doi: 10.1097/00055735-200008000-00011</mixed-citation></ref><ref id="B14"><label>14.</label><mixed-citation>Foroozan R, Tabas JG, Moster ML. Recurrent microhyphema despite intracapsular fixation of a posterior chamber intraocular lens. J Cataract Refract Surg. 2003;29(8):1632–1635. doi: 10.1016/s0886-3350(03)00122-6</mixed-citation></ref><ref id="B15"><label>15.</label><mixed-citation>Egorova EV, Malyugin BE, Uzunian DG, Polyanskaya EG. Initial changes of capsular bag after phacoemulsification with implantation intraocular lens by means ultrasound biomicroscopy. The Siberian scientific medical journal. 2009;(4):12–15. EDN: KZRFGV</mixed-citation></ref><ref id="B16"><label>16.</label><mixed-citation>Egorova EV, Polyanskaya EG, Morozova TA, et al. Acoustic morphology of cataract capsule contracture. OSU Bulletin. 2011;(14):104–107. EDN: PCGXZN (In Russ.)</mixed-citation></ref><ref id="B17"><label>17.</label><mixed-citation>Scholl S, Kirchhof J, Augustin AJ. Pathophysiology of macular edema. Ophthalmologica. 2010;224(S1):8–15. doi: 10.1159/000315155</mixed-citation></ref><ref id="B18"><label>18.</label><mixed-citation>Chu CJ, Johnston RL, Buscombe C, et al. Risk factors and incidence of macular edema after cataract surgery: A database study of 81 984 eyes. Ophthalmology. 2016;123(2):316–323. doi: 10.1016/j.ophtha.2015.10.001</mixed-citation></ref><ref id="B19"><label>19.</label><mixed-citation>Wintle R, Austin M. Pigment dispersion with elevated intraocular pressure after AcrySof intraocular lens implantation in the ciliary sulcus. J Cataract Refract Surg. 2001;27(4):642–644. doi: 10.1016/s0886-3350(00)00792-6</mixed-citation></ref><ref id="B20"><label>20.</label><mixed-citation>Chen TC, Jurkunas U, Chodosh J. A patient with glaucoma with corneal edema. JAMA Ophthalmol. 2020;138(8):917–918. doi: 10.1001/jamaophthalmol.2020.1023</mixed-citation></ref><ref id="B21"><label>21.</label><mixed-citation>Mehta R, Aref AA. Intraocular lens implantation in the ciliary sulcus: Challenges and risks. Clin Ophthalmol. 2019;13:2317–2323. doi: 10.2147/OPTH.S205148</mixed-citation></ref><ref id="B22"><label>22.</label><mixed-citation>Potyomkin VV, Ageeva EV. Zonular instability in patients with pseudoexfoliative syndrome: the analysis of 1000 consecutive phacoemulsifications. Ophthalmology Reports. 2018;11(1):41–46. doi: 10.17816/OV11141-46 EDN: YVLXBA</mixed-citation></ref><ref id="B23"><label>23.</label><mixed-citation>Potemkin VV. Pseudoexfoliation syndrome without concomitant increase in intraocular pressure: comprehensive examination and surgical rehabilitation [dissertation]. Saint Petersburg; 2024. 343 p. (In Russ.)</mixed-citation></ref><ref id="B24"><label>24.</label><mixed-citation>Pillai MR, Balasubramaniam N, Wala N, et al. Glaucoma in uveitic eyes: Long-term clinical course and management measures. Ocul Immunol Inflamm. 2024;32(6):1041–1047. doi: 10.1080/09273948.2023.2202740</mixed-citation></ref><ref id="B25"><label>25.</label><mixed-citation>Seow WH, Lim CHL, Lim BXH, Lim DK-A. Uveitis and glaucoma: a look at present day surgical options. Curr Opin Ophthalmol. 2023;34(2):152–161. doi: 10.1097/ICU.0000000000000940</mixed-citation></ref><ref id="B26"><label>26.</label><mixed-citation>Lippera M, Nicolosi C, Vannozzi L, et al. The role of anterior segment optical coherence tomography in uveitis–glaucoma–hyphema syndrome. Eur J Ophthalmol. 2022;32(4):2211–2218. doi: 10.1177/11206721211063738</mixed-citation></ref><ref id="B27"><label>27.</label><mixed-citation>Piette S, Canlas OA, Tran HV, et al. Ultrasound biomicroscopy in uveitis–glaucoma–hyphema syndrome. Am J Ophthalmol. 2002;133(6): 839–841. doi: 10.1016/s0002-9394(02)01386-7</mixed-citation></ref><ref id="B28"><label>28.</label><mixed-citation>De Simone L, Mautone L, Aldigeri R, et al. Anterior segment optical coherence tomography in uveitis–glaucoma–hyphema syndrome. Ocul Immunol Inflamm. 2024;32(9):2085–2091. doi: 10.1080/09273948.2024.2323094</mixed-citation></ref></ref-list></back></article>
